Seed to Series B Life Sciences Venture Capital Investment
LifeArc Ventures provides venture capital investment and scientific support to early-stage life sciences companies, typically from Seed to Series B. It invests across therapeutics, HealthTech and MedTech, supporting innovative technologies with the potential to deliver significant patient benefit. Opportunities are considered through direct engagement with the investment team.
About the opportunity
LifeArc Ventures invests in innovative, science-led companies developing technologies and therapies with the potential to transform patient outcomes.
Eligibility and investment focus
- Early-stage companies seeking Seed to Series B investment.
- Therapeutics, HealthTech and MedTech innovations.
- Novel technologies or assets with strong scientific foundations and protectable intellectual property.
- Companies led by exceptional scientific founders and teams.
- Primarily focused on UK life sciences innovation, with capacity to invest internationally.
Support available
LifeArc Ventures offers venture capital funding, with follow-on investment available to successful portfolio companies. It also provides scientific and translational expertise, strategic advice, industry connections and access to specialist laboratory support where appropriate.
How to apply
This is an ongoing investment proposition rather than a time-limited funding competition. Interested companies can contact LifeArc Ventures directly through its website to discuss their innovation and potential investment.
Funding type: Venture capital / equity investment.
- Funding Organisation
- LifeArc Ventures
- Status
- Apply Anytime
- Closing date
- Apply Anytime
- Funder type
- Charity
- Funding type
- Equity Investment
- Eligible organisation
- Companies
- Geographic eligibility
- Global
- Area in health
- Medical devices, Software, Therapeutics
- Use of funding
- Corporate Investment, Product Development, Research